Q: WHAT IS THE COLLABORATION BETWEEN COLUMBIA UNIVERSITY AND DEERFIELD MANAGEMENT COMPANY?
A: Columbia is collaborating with Deerfield, an investment firm dedicated to advancing healthcare, to accelerate the translation of research in Columbia faculty laboratories into clinical therapeutics. Hudson Heights is a Deerfield company that will support Columbia’s innovative translational research and leverage Deerfield’s expertise in accelerating state-of-the-art drug development. Hudson Heights will fund projects with the aim of discovering novel therapeutics to cure life-altering diseases. Through Hudson Heights, Deerfield has committed up to $130 million in initial funding to support promising Columbia translational research. This collaboration will provide operational support and may make additional capital investments into spin-off companies that emerge from Hudson Heights projects that show commercial potential.
Q: WHO IS ELIGIBLE TO APPLY?
A: Principal Investigators whose principal employer is Columbia University or Columbia University Irving Medical Center or who have a faculty appointment at Columbia University or Columbia University Irving Medical Center and are therefore subject to Columbia’s institutional policies are eligible to apply.
Q: HOW CAN I APPLY?
A: To submit an application, please click here to learn more information.
Q: DOES HUDSON HEIGHTS HAVE A THERAPEUTIC AREA OF INTEREST?
A: No – We welcome applications from all therapeutic areas.
Q: HOW MANY CALLS FOR PROPOSAL ARE THERE IN A YEAR?
A: There will be at least one call for proposals per calendar year.